| 1 |
33979727 | SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues. | 2021 Aug |
1 |
| 2 |
34641952 | Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. | 2021 Oct 12 |
2 |
| 3 |
32576829 | Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis. | 2020 Jun 23 |
3 |
| 4 |
32581304 | SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine. | 2020 Jun 24 |
1 |
| 5 |
30290238 | From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections. | 2019 Mar |
1 |
| 6 |
27991919 | SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. | 2017 Feb |
2 |
| 7 |
28046007 | Substrates and Inhibitors of SAMHD1. | 2017 |
1 |
| 8 |
28220857 | SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells. | 2017 Feb 21 |
1 |
| 9 |
28359840 | SAMHD1 is active in cycling cells permissive to HIV-1 infection. | 2017 Jun |
3 |
| 10 |
28436707 | SAMHD1 protects cancer cells from various nucleoside-based antimetabolites. | 2017 Jun 3 |
1 |
| 11 |
28502830 | With me or against me: Tumor suppressor and drug resistance activities of SAMHD1. | 2017 Aug |
1 |
| 12 |
26496699 | The Frequency of Cytidine Editing of Viral DNA Is Differentially Influenced by Vpx and Nucleosides during HIV-1 or SIVMAC Infection of Dendritic Cells. | 2015 |
2 |